Lab News
Congratulations!
Musa received the MPower Fellowship. Congrats!!!
The Gould Lab welcomes a new lab member, Nushrat.
The Gould Lab welcomes new lab members, Maisie, Maithily, and Darrell.
Kyle publishes
Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient in Neuropsychopharmacology.
Evan publishes,
Relative to females, male rats are more willing to forego obtaining sucrose reward in order to prevent harm to their cage mate, in Psychopharmacology.
The Gould Lab welcomes new lab members, Phylicia and Ryan.
Dr. Gould is invited to speak for the scientific session at the 61st Annual Meeting of the Psychiatric Research Society in Park City, Utah.
Evan publishes a perspective article,
Possible psychedelic therapeutic mechanism, in Science.
Kyle presents his research at the 61st Annual ACNP Meeting in Phoenix, Arizona.
Sarah is awared a 2022 Brain and Behavior Research Foundation Young Investigator Grant to study the role of T cells in postnatal BNST development and social behavior.
Sarah receives the 2022 Betty Huse Award from the Department of Psychiatry at University of Maryland School of Medicine as the co-investigator with Dr. Leon Brown as the principal investigator to conduct "an anatomical investigation of the lateral habenula and its role in ADHD".
The Gould Lab welcomes new lab members, Abagail and Musa.
Morris presents his research at Immunology 2022 conference in Portland, Oregon.
Lace is awarded the 2022 Society for Biological Psychiatry Predoctoral Scholars Travel Fellowship Award.
Poly presents her research at 60th Annual American College of Neuropsychopharmacology Meeting in San Juan, Puerto Rico.
Morris presents his research at Silvio O. Conte Center Virtual Research Symposium.
Poly is invited to present at Johns Hopkins Department of Psychiatry and Behavioral Sciences Research Conference.
Evan receives a fellowship through the Maryland Psychiatric Research Center NIH/NIMH T32 grant.
Lace is among only 25 neuroscientists in the nation who were selected for the prestigious NIH Outstanding Scholars in Neuroscience Award Program.
Poly is awarded the prestigious Marie Skłodowska-Curie Fellowship to investigate "Reciprocal interactions between hypogonadism and epigenetic modifications: A path for the development of personalized treatments for depression".
Dr. Gould receives promotion to full Professor of the Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology.
The #sex of human experimenters affects mouse behaviors and responses following administration of the rapid-acting antidepressant #ketamine
— Nature Neuroscience (@NatureNeuro) August 30, 2022
New from @PolymniaG @pzanos @ScireAnimus @anxiaoxian520 @dmgerhard and colleagueshttps://t.co/ikvHtuD302
Dr. Gould is quoted in Psychedelic drugs take on depression by Cassandra Willyard in Nature Outlook.
News Features
Gould lab was featured in the
holiday video from the Neuro Networks podcast team.
Ketamine metabolite, (2R,6R)-hydroxynorketamine,
was observed to be safe and no dissociative side effects in Phase I clinical trial. See Dr. Gould's comments on this exciting development!
Dr. Gould comments on a new study that investigates ketamine trapping in the NMDAR to alleviate depressive symptoms in the hyperactive lateral habenula in a new PNAS article,
Ketamine interrupts machine gun-like neural activity to alleviate depression.
Dr. Gould and Evan were quoted in an August 2024 PsyPost article:
Ketamine as an entactogen: Scientists reveal intriguing impact on social pleasure and empathy.
Dr. Gould was quoted in a June 2024 American Psychological Association (APA) article, The emergence of psychedelics as medicine.
Dr. Gould was quoted in a December, 2023 Healthline News article, Deepak Chopra Shares
How Psychedelics May Help Treat Depression, PTSD, and More.
Dr. Gould was featured in a faculty spotlight in UMB's Programs in Neuroscience (PIN)
2023 BrainStorm Newsletter. It includes a detailed Q&A where you can learn more about the man behind the helm!
Dr. Gould discusses a previous study linking allergen exposures to altered cytokine levels as well as anxiety-like behaviors in rodents in The Connection Between Seasonal Allergies and Mental Health
by Christina Caron in The New York Times.
Dr. Gould comments on the potential of using ketamine as a basis to develop other new molecules with antidepressant properties but not the adverse side effects in
Ketamine: Could this anesthetic be the key to treating neurological disorders? by Adam Zamecnik in Pharmaceutical Technology.
Dr. Gould talks about ketamine's off-label use and how it works to relieve symptoms of depression in a news article for Verywell Mind titled
One Woman’s Journey and Success With Ketamine Therapy by Cathy Cassata.
Lace is interviewed by Adam Levy on the Knowable Podcast, talking about
How antidepressants changed ideas about depression. .
Dr. Gould talks about ketamine's mechanisms of actions and down stream effectors as well as ketamine metabolite, (2R, 6R)-HNK's invovlement in antidepressant effects in
Are Psychedelics the Next Big Treatment for Depression? by Hannah Thomasy in The Daily Beast.
Lace is awarded the Elaine Miye Otani Memorial Award for outstanding character and service from the University of Maryland School of Medicine Graduate Program In Life Sciences.
Poly receives the 2020 Betty Huse Prize, for her project "Targeting of Estrogen Receptors for the Treatment of Adolescent Depression" from the Department of Psychiatry at University of Maryland School of Medicine.
Lace is awarded a Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institute of Mental Health.
Lace is awarded the Attillo R. and Myrtle L. Jackson Award, for "meritorious service to humanity that is continually demonstrated by on-going acts of generosity and kindness through outreach to underserved populations" by the IMSD Leadership and Meyerhoff Programs.
Poly receives the 2019 Postdoctoral Fellow Excellence in Research Award from the University of Maryland School of Medicine.
Dr. Gould receives the 2019 Faculty Excellence in Postdoctoral Mentorship Award from the University of Maryland School of Medicine.
Poly is promoted to Instructor in the Department of Psychiatry, University of Maryland School of Medicine.
Panos is promoted to Assistant Professor in the Department of Psychiatry, University of Maryland School of Medicine.
Lace earns best poster presentation at the 2019 Society for Neuroscience Greater Baltimore Chapter Meeting.
Lace is accepted into the Society for Neuroscience Leadership Development Program.
Lace is awarded the Trainee Professional Development Award from the Society for Neuroscience.
Lace earns best poster presentation at the 2019 Department of Psychiatry Research Day.
Brent is accepted into the Ph.D. program in Neuroscience at the University of Maryland School of Medicine.
Lace is selected as a speaker for the Program in Neuroscience Annual Retreat.
The Gould Lab welcomes new lab members, Morris, Adele, and Sarah.
Carleigh is accepted into the M.S. program in Molecular Medicine at the University of Maryland School of Medicine.
Lace is awarded a training grant from the Training Program in Integrative Membrane Biology funded by the NIH National Institute of General Medical Sciences.
Jackie earns best poster presentation at the 2018 Department of Psychiatry Research Day.
Lace is a national finalist for the Howard Hughes Medical Institute, Gilliam Fellowship for Advanced Study.
Poly receives a 2017 Travel Award to present at the Society of Biological Psychiatry.
Panos receives a 2016 Travel Award to present at the Society of Biological Psychiatry.
Panos receives the 2017 Postdoctoral Scholar Award from the University of Maryland School of Medicine.
Jackie is awarded a training grant from the Training Program in Integrative Membrane Biology funded by the NIH National Institute of General Medical Sciences.
Lace is awarded the Student of Merit training grant from the Program in Neuroscience funded by the NIH National Institute of Neurological Disorders and Stroke.
Dr. Gould receives the , an annual award offered in both basic science and in clinical sciences for the purpose of stimulating international research in biological psychiatry by young investigators.
- Lace discusses significance of glutamate release in ketamine's mechanisms of actions in
How Ketamine Helps Alleviate Depression by Brianna Randall in Discover Magazine.
- Dr. Gould comments on the relevance of NMDA-receptor-independent ketamine mechanisms of actions in response to a recent structural study examining receptor binding in
High-resolution snapshot of ketamine-receptor handshake may point to better antidepressants in Chemical & Engineering News by Alla Katsnelson.
- Dr. Gould discusses ketamine mechanisms of actions in
More Than Just a Trip: Why Does Ketamine Work for Depression When Nothing Else Does? by Darisse Smith.
- Dr. Gould discusses ketamine mechanisms of actions in
Ketamine is revolutionizing antidepressant research, but we still don’t know how it works in Chemical & Engineering News by Michael Torrice.
- Lace is featured in SOMnews
Learning to Lead: UMSOM GPILS Student Qualifies for Exclusive Leadership Program published by the University of Maryland School of Medicine.
- Dr. Gould discusses new antidepressants in
Antidepressants Could Herald New Era in Psychiaytic Drugs by Bianca Nogrady.
- Dr. Gould discusses the use of preclinical behavioral assays in
Depression researchers rethink popular mouse swim tests by Sara Reardon.
- Work from the Gould Lab is discussed in the NIMH Director's Message,
I'm Optimistic about Depression, by Joshua Gordon.
- Dr. Gould is featured in University of Maryland School of Medicine News in
UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine by Joanne Morrison.
- Dr. Gould and Dr. Scott M. Thompson discuss the risks and rewards of intranasal S-ketamine in
Listening to ketamine from Knowable Magazine from Annual Reviews by Emily Underwood.
- Dr. Gould comments Newsweek on the
Parkland and Sandy Hook Suicides: What Scientists Know about How Brain Scans Can Detect Suicide Thoughts, Risks by Adam Piore.
- Dr. Gould comments in the New York Times about Fast-Acting Depression Drug, Newly Approved, Could Help Millions
- Dr. Gould is featured as a Faculty Spotlight in the
What's On! In Brain Sciences publication.
- Dr. Gould and Dr. Scott M. Thompson are featured in SOMnews Research and Discovery about
WORKING TOGETHER TO DEVELOP NEW, RAPID-ACTING TREATMENTS FOR DEPRESSION.
- Dr. Georgiou and Dr. Gould is featured in Nature Reviews Drug Discovery about ketamine,
'Party drug' turned antidepressant approaches approval by Sara Reardon.
- The research conducted by Poly is featured on Nature News about how
Sex matters in experiments on party drug — in mice by Sara Reardon.
- Dr. Gould is featured by Research Publishing International on a Neuroscience Research Portfolio about
Fighting Depression with ketamine.
- Dr. Gould is interviewed by Kat Arney at The Naked Scientists regarding ketamine as a
Dream depression drug.
- Panos is interviewed by Jesse Lawler at Smart Drug Smarts about
Treating Depression with Ketamine.
Dr. Gould talks about the findings of Georgiou et al., (2022) Nat Neurosci in UMSOM Frontline News coverage.
Panos is featured by the University of Maryland School of Medicine, in regards to his investigations of ketamine and its metabolites for treatment-resistant depression.